Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James W Shaw

Showing results (11-20 of 57) with videos related to

Pageof 6
Sort By:
Pharmacoeconomics|January 31, 2002
Onychomycosis: health-related quality of life considerationsJames W Shaw, Vijay N Joish, Stephen Joel Coons
Social Science & Medicine (1982)|June 18, 2010
Application of directional statistics to health state valuation: a commentary on Craig and OppeJames W Shaw, A Simon Pickard, Ronald R Yager
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|November 20, 2024
EQ-5D-5L value set for Norway: a hybrid model using cTTO and DCE dataAndrew M Garratt, Knut Stavem, James W Shaw, et al.
Clinicoeconomics and Outcomes Research : CEOR|August 1, 2015
Retrospective analysis of drug utilization, health care resource use, and costs associated with IFN therapy for adjuvant treatment of malignant melanomaYing Zhang, Trong Kim Le, James W Shaw, et al.
Medical Care|December 25, 2008
Relative efficiency of the EQ-5D, HUI2, and HUI3 index scores in measuring health burden of chronic medical conditions in a population health survey in the United StatesNan Luo, Jeffrey A Johnson, James W Shaw, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|June 5, 2007
A comparison of EQ-5D index scores derived from the US and UK population-based scoring functionsNan Luo, Jeffrey A Johnson, James W Shaw, et al.
Clinicoeconomics and Outcomes Research : CEOR|April 3, 2019
Relative value assessment: characterizing the benefit of oncology therapies through diverse survival metrics from a US perspectiveRichard Macaulay, Amit Ahuja, Ebenezer Ademisoye, et al.
The Patient|December 12, 2023
A Review of the Use of EQ-5D for Clinical Outcome Assessment in Health Technology Assessment, Regulatory Claims, and Published LiteratureCaroline Shaw, Louise Longworth, Bryan Bennett, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|July 20, 2019
A comparison of self-rated health using EQ-5D VAS in the United States in 2002 and 2017Ashley S Cha, Ernest H Law, James W Shaw, et al.
Health and Quality of Life Outcomes|August 12, 2024
A scoping review of the use of minimally important difference of EQ-5D utility index and EQ-VAS scores in health technology assessmentCaroline Shaw, Louise Longworth, Bryan Bennett, et al.
Pageof 6

Showing results (11-20 of 57) with videos related to

Sort By:
Pageof 6
Pharmacoeconomics|January 31, 2002
Onychomycosis: health-related quality of life considerationsJames W Shaw, Vijay N Joish, Stephen Joel Coons
Social Science & Medicine (1982)|June 18, 2010
Application of directional statistics to health state valuation: a commentary on Craig and OppeJames W Shaw, A Simon Pickard, Ronald R Yager
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|November 20, 2024
EQ-5D-5L value set for Norway: a hybrid model using cTTO and DCE dataAndrew M Garratt, Knut Stavem, James W Shaw, et al.
Clinicoeconomics and Outcomes Research : CEOR|August 1, 2015
Retrospective analysis of drug utilization, health care resource use, and costs associated with IFN therapy for adjuvant treatment of malignant melanomaYing Zhang, Trong Kim Le, James W Shaw, et al.
Medical Care|December 25, 2008
Relative efficiency of the EQ-5D, HUI2, and HUI3 index scores in measuring health burden of chronic medical conditions in a population health survey in the United StatesNan Luo, Jeffrey A Johnson, James W Shaw, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|June 5, 2007
A comparison of EQ-5D index scores derived from the US and UK population-based scoring functionsNan Luo, Jeffrey A Johnson, James W Shaw, et al.
Clinicoeconomics and Outcomes Research : CEOR|April 3, 2019
Relative value assessment: characterizing the benefit of oncology therapies through diverse survival metrics from a US perspectiveRichard Macaulay, Amit Ahuja, Ebenezer Ademisoye, et al.
The Patient|December 12, 2023
A Review of the Use of EQ-5D for Clinical Outcome Assessment in Health Technology Assessment, Regulatory Claims, and Published LiteratureCaroline Shaw, Louise Longworth, Bryan Bennett, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|July 20, 2019
A comparison of self-rated health using EQ-5D VAS in the United States in 2002 and 2017Ashley S Cha, Ernest H Law, James W Shaw, et al.
Health and Quality of Life Outcomes|August 12, 2024
A scoping review of the use of minimally important difference of EQ-5D utility index and EQ-VAS scores in health technology assessmentCaroline Shaw, Louise Longworth, Bryan Bennett, et al.
Pageof 6